TargetMol

INOSINIC ACID

Product Code:
 
TAR-T4685
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T4685-25mg25mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4685-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4685-50mg50mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4685-100mg100mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Inosinic acid is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Inosinic acid is a nucleotide present in muscle and other tissues. It is formed by the deamination of AMP and when hydrolysed produces inosine. Inosinic acid is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine.Inosine 5?-monophosphate (IMP) is used as a substrate to study the distribution, specificity and kinetics of inosine-5?-monophosphate dehydrogenase (IMPDH).
CAS:
131-99-7
Formula:
C10H13N4O8P
Molecular Weight:
348.208
Pathway:
Metabolism
Purity:
0.9975
SMILES:
O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)n1cnc2c1nc[nH]c2=O
Target:
Endogenous Metabolite

References

Green H J , Grant S M , Phillips S M , et al. Reduced muscle lactate during prolonged exercise following induced plasma volume expansion[J]. Canadian Journal of Physiology and Pharmacology, 1997, 75(12):1280-1286. Nakayama Y . Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition[J]. Theoretical Biology and Medical Modelling,2,1(2005-05-09), 2005, 2(1):18-18. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis. Castro-Gago M , Cid E , Trabazo S , et al. Cerebrospinal Fluid Purine Metabolites and Pyrimidine Bases After Brief Febrile Convulsions[J]. Epilepsia, 1995, 36(5):471-474. Snow R J , Mcconell G K , Shinewell J , et al. Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans[J]. Med Sci Sports Exerc, 2005, 37(12):2054-2061. Chen J, Li T, Huang D, et al.Integrating UHPLC-MS/MS quantitative analysis and exogenous purine supplementation to elucidate the antidepressant mechanism of Chaigui granules by regulating purine metabolism.Journal of Pharmaceutical Analysis.2023